TrialAntimicrobial agents and chemotherapy2020

A Prospective, Randomized, Open-Label Trial of Early versus Late Favipiravir Therapy in Hospitalized Patients with COVID-19.

Yohei Doi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.